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Abstract
Background: Tetherin (BST-2/CD317/HM1.24) is an interferon (IFN)-inducible factor of the innate immune system,
recently shown to exert antiviral activity against HIV-1 and other enveloped viruses by tethering nascent viral
particles to the cell surface, thereby inhibiting viral release. In HIV-1 infection, the viral protein U (Vpu) counteracts
this antiviral action by down-modulating tetherin from the cell surface. Viral dissemination between T-cells can
occur via cell-free transmission or the more efficient direct cell-to-cell route through lipid raft-rich virological
synapses, to which tetherin localizes.
Results: We established a flow cytometry-based co-culture assay to distinguish viral transfer from viral transmission
and investigated the influence of tetherin on cell-to-cell spread of HIV-1. Sup-T1 cells inducible for tetherin
expression were used to examine the impact of effector and target cell tetherin expression on virus transfer and
transmission. Using this assay, we showed that tetherin inhibits direct cell-to-cell virus transfer and transmission.
Viral Vpu promoted viral transmission from tetherin-expressing cells by down-modulating tetherin from the effector
cell surface. Further, we showed that tetherin on the target cell promotes viral transfer and transmission. Viral
infectivity in itself was not affected by tetherin.
Conclusion: In addition to inhibiting viral release, tetherin also inhibits direct cell-to-cell spread. Viral protein Vpu
counteracts this restriction, outweighing its possible cost of fitness in cell-to-cell transmission. The differential role
of tetherin in effector and target cells suggest a role for tetherin in cell-cell contacts and virological synapses.
Background
Tetherin (BST-2/CD317/HM1.24) is a recently identified
component of innate cellular defense against viral infec-
tion and is active against HIV-1 and other enveloped
viruses [1-5]. Tetherin inhibits viral release from infected
cells, tethering nascent viral particles to the cell surface
and to each other [3,5,6]. The primary site of action of
tetherin is the cellular surface membrane [3,5,7].
In HIV-1 infection, the viral protein Vpu can promote
down-modulation of tetherin cell surface expression as
well as its subsequent degradation, leading to increased
viral release [3,5,8]. Various models have been proposed
to link cellular and viral membranes in tetherin-
mediated restriction of viral release [3,5,6]. Since
tetherin is incorporated into the viral membrane, it may
function by directly linking viral and cellular membranes
during viral budding through a double anchorage
mechanism [6]. It has been suggested that tetherin, in
addition to restricting viral release, may also abrogate
the infectivity of released HIV-1 particles [9].
Retroviral spread can occur via cell-free and more effi-
cient direct cell-to-cell transmission [10-14] (reviewed in
[15,16]). Direct cell-to-cell dissemination between an
infected ‘effector’ cell and an uninfected ‘target’ cell
occurs via intercellular contact zones termed virological
synapses that temporarily connect polarized cells
[13,17-22]. Virological synapses seem to share structural
features with the common immunological synapses that
play key roles in cell-mediated immunity [17,19,23-25].
Direct cell-to-cell spread via the virological synapse is
thought to be a major mode of HIV-1 dissemination in
both T-cell lines and in secondary lymphoid tissue
[14,20,26-28]. It is possible that cell-to-cell spread may
be physically protected from neutralizing antibodies and
antiretroviral drugs that target viral entry [14,26,29-33].
Furthermore, it was recently argued that direct cell-
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restriction by the innate immune system [34].
Tetherin is an integral membrane protein that com-
bines a conventional transmembrane domain with a gly-
cosyl-phosphatidylinositol (GPI) anchor [35]. At the cell
surface, the GPI anchor resides in lipid rafts while the
transmembrane domain is thought to localize to the
interface of membrane microdomains in ring-like struc-
tures [35-38], from where it is down-modulated by Vpu
[39]. Lipid raft-rich membrane microdomains were
recently shown to be involved in direct cell-to-cell
spread of HIV-1 via virological synapses [17,19,40,41].
While cell-free spread of HIV-1 is abrogated by
tetherin-mediated restriction of viral release, the accu-
mulation of HIV-1 particles at lipid rafts may alter
direct cell-to-cell spread through the virological synapse,
as was recently reported for HTLV-1 [42].
Viral infections are also capable of inducing polariza-
tion in otherwise non-polarized cells, such as CD4+ T-
lymphocytes, in which lipid rafts focus viral entry,
assembly and budding [40,41,43,44]. At the virological
synapse, virus is recruited to polarized lipid raft domains
in transmitting effector cells, while viral receptors neces-
sary for attachment and entry are recruited to the
synapse of the target cell in an actin-dependent manner
[13,19]. Disturbance of lipid rafts inhibits viral particle
production [45,46] and Vpu-mediated viral release [47],
as well as the formation of virological synapses [19].
Tetherin has recently been shown to modulate actin
cytoskeletal structures in both polarized and non-polar-
ized cells [37]. The structure and localization of tetherin
further suggest that it may act as a physical link between
cytoskeleton architecture and the plasma membrane in
lipid rafts [35-38]. However, little is known about the
role of tetherin in virological synapses and the impact of
tetherin cell surface expression in effector and target
cells on direct cell-to-cell transfer and transmission of
HIV-1. Two recent studies reported contradicting data
on the role of tetherin in cell-to-cell spread of HIV-1
[48,49]. One study described an inhibiting effect of
tetherin on cell-to-cell spread of HIV-1 in absence of
Vpu, while also abrogating viral infectivity of transferred
virus [49]. Another study reported that tetherin does
not restrict HIV-1 cell-to-cell spread, irrespective of
Vpu, and also reported an increase of synapse formation
with enriched tetherin content at the synapse in the
absence of Vpu [48].
Here, we have investigated the impact of cell surface
tetherin on HIV-1 cell-to-cell spread using a T-cell line
(human T-cell lymphoma cell line Sup-T1), that is indu-
cible for tetherin expression. We found that the pre-
sence of tetherin on effector cells diminished HIV-1
cell-to-cell transfer and transmission, and that this activ-
ity could be antagonized by Vpu. However, when
effector cells lacked tetherin expression, Δvpu virus
spread more efficiently than wt virus. When expressed
on target cells, tetherin promoted viral cell-to-cell trans-
fer and transmission. Tetherin did not exert a direct
effect upon the infectiousness of transferred virus.
Methods
Cells and viruses
Sup-T1 cells containing the human tetherin gene
(tetherin
pos) as well as negative control cells (tetherin
neg),
i.e. cells transduced with an empty vector, have been
previously described, and Vpu-dependence of viral
release in tetherin
pos cells has been confirmed [9]. Cells
were maintained in RPMI-1640 supplemented with 10%
tetracycline-free bovine serum albumin (BSA), 2 μg/ml
puromycin (Sigma), and 1 mg/ml G418 (Sigma). Tetherin
expression was induced by adding 0.1 μg/ml doxycycline
(Sigma). Cell surface expression of tetherin was assessed
by flow cytometry. The viral clone pBR-NL43-IRES-eGFP
was obtained from the NIH AIDS Research and Refer-
ence Reagent Program. This viral clone expresses green
fluorescent protein (GFP) from an internal ribosomal
entry site downstream of nef [50]. Site-directed mutagen-
esis, using the QuickChange II XL Site-Directed Muta-
genesis Kit (Stratagene), was used to introduce
nucleotide changes into the coding region of vpu, result-
ing in two stop codons at amino acid positions 1 and 3
(pBR-NL43-IRES-eGFP Δvpu). Virus was produced in
293T cells using Lipofectamine2000 (Invitrogen) as a
transfection reagent. Virus was collected after 48 h,
filtered (0.45 μm), and viral capsid/p24 protein (CA p24)
content was quantified by VIRONOSTIKA HIV-1 Ag kit
(bioMérieux).
HIV-1 infections
For experiments on cell-to-cell transmission, effector
cells (tetherin
pos or tetherin
neg) were infected with 600
ng CA p24/10
6 cells by spinoculation (1,500 × g, at 37°
C, 2 h), followed by incubation for 1 h at 37°C, after
which virus was removed. The spinocultion method
was used to synchronize infections. Cells were culti-
vated for 48 h, at which time the cell population con-
tained 10-12% GFP
pos cells as assessed by flow
cytometry, thus minimizing superinfection events. To
study initial infection kinetics, cells were infected with
350 ng CA p24/10
6 cells.
Western Blot analysis
To verify the absence of Vpu production from the Δvpu
viral clone, cells were infected with both wt virus and a
Δvpu viral clone. Western blots of cellular lysates were
probed with antibodies against the viral proteins Vpu
(rabbit, NIH AIDS Research and Reference Reagent Pro-
gram [51]) and CA p24 (mouse, ID Labs Inc.), followed
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secondary antibodies (Sigma).
Expression levels of viral Env and CA p24 in viral par-
ticles were assessed from the supernatants of transfected
293T cells (described above). Viral particles were
enriched by ultracentrifugation (48,000 × g, 1 h, 4°C).
Viral lysates were probed with primary antibodies
against Env (rabbit, Abnova) and CA p24 (mouse, ID
Lab Inc.) as well as horseradish peroxidase-conjugated
secondary antibodies matching the origin of the primary
antibody (Sigma). Quantification of viral Env, relative to
CA p24, was performed using ImageJ software, following
the manufacturer’s protocol for ImageJ Gel Analysis
documentation.
Intracellular and extracellular staining
For flow cytometry cells were stained for tetherin on the
cell surface and for intracellular CA p24. Staining for
cell surface tetherin was performed using a primary rab-
bit anti-human-tetherin polyclonal antibody (1:3000)
(NIH AIDS Research and Reference Reagent Program
[52]), followed by a peridinin chlorophyll protein
(PerCP)-labeled secondary goat anti-rabbit antibody
(1:250) (Santa Cruz Biotechnology). Cells were fixed in
4% paraformaldehyde for 25 min, permeabilized using
saponin-containing Wash/Perm solution (BD
Bioscience), and stained for intracellular Gag CA p24
using an RD1-labeled mouse anti-CA p24 monoclonal
antibody (1:100) (Beckman Coulter). Cell surface stain-
ing and intracellular staining were performed at 4°C for
30 minutes. Samples were analyzed by flow cytometry.
For confocal microscopy cells were stained for tetherin
and actin; the virus derived GFP signal was amplified by
GFP specific staining. Cells were seeded and fixed on
coverslips in 4% paraformaldehyde for 25 min and were
stained for cell surface tetherin using a primary rabbit
anti-human-tetherin antibody (1:3000), followed by addi-
tion of anti-rabbit Alex 647-labeled antibody (Invitrogen;
1:400). Cells were then permeabilized using Wash/Perm
solution and incubated with Alexa 594-labeled phaloidin
(Invitrogen; 1 unit) and anti-GFP Alexa 488-labeled
antibody (Invitrogen; 1:400). Cells were scanned using a
Zeiss LSM 5 Pascal microscope.
Analysis of cell-free viral infections, cell-to-cell transfer
and transmission by flow cytometry
To assess the impact of tetherin and Vpu on the kinetics
of initial viral infection, cells (tetherin
pos or tetherin
neg)
were infected with wt or Δvpu virus. Expression levels
of viral-derived GFP were determined during the initial
48 h of infection.
To investigate the impact of tetherin on cell-to-cell
transfer and transmission, effector cells were infected
with wt or Δvpu virus 48 h prior to setting up co-culture.
Target cells were stained with 5 μM 7-amino-4-chloro-
methylcoumarin (CMAC) (Molecular Probes) at 37°C for
25 min 24 h prior to starting the co-cultivation. Effector
and target cells were seeded at a 2:1 ratio to a final con-
centration of 0.9 × 10
6 cells/ml in a final volume of 2 ml
in 12-well plates, either in mixed co-culture or separated
in transwell chambers with a virus-permeable membrane
(3 μm pore size) (NUNC). Virus transfer was assessed by
flow cytometry for viral CA p24 in target cells at 6 h after
the start of co-culture; virus transmission was evaluated
by flow cytometry for virus-derived GFP expression in
target cells after 30 h of co-culture. All samples were ana-
lyzed using a LSRII instrument (Becton Dickinson), and
FACSDiva 6.1 software (Becton Dickinson) or FlowJo 7.5
software (Tree Star).
Data analysis
Results of at least three independent experiments are
expressed as means ± standard error of the mean
(SEM). Data were analyzed utilizing GraphPad PRISM 5
software. Differences between two groups were tested
for statistical significance using a t-test, while differences
between groups of three and more were tested for statis-
tical significance using one-way ANOVA. The p-value
obtained from group analyses reflects the overall signifi-
cance of differences between experimental groups and
control groups. Statistical differences between individual
groups and their respective control are not stated as
exact p-values.
Results
Vpu down-modulates induced tetherin cell surface
expression in a stably transduced T-cell line
W ef i r s tc o n f i r m e di no u rs y s t e mt h a tV p uw a sn o t
e x p r e s s e df r o maΔvpu viral clone by Western blot
(Figure 1A) and then established the ability of the human
T-cell line, Sup-T1, stably transduced with human
tetherin (tetherin
pos), to express tetherin on its cell sur-
face by flow cytometry upon induction by doxycycline
[9]. Cell surface expression of tetherin was induced in
tetherin
pos cells, but not in control Sup-T1 cells (tether-
in
neg) (stably transduced with an empty vector), following
addition of doxycycline [9] and established that induced
tetherin is stably expressed on the cell surface for at least
72 h (p > 0.4; Figure 1B). Next, we assessed the effect of
Vpu on cell surface expression of tetherin in cell popula-
tions that were infected with GFP-encoding wt or Δvpu
BR-NL43-IRES-eGFP viral clone by flow cytometry. Cells
were gated into infected and uninfected populations at
48 h post infection (p.i.) based on presence of GFP, as a
marker for viral gene expression from BR-NL43-IRES-
eGFP. Tetherin surface levels were determined for
infected and uninfected cells. In tetherin
pos cells infected
with wt virus, tetherin surface levels were found to be
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cells (p > 0.0001), while tetherin
pos cells infected with
Δvpu virus showed high levels of surface expression (Fig-
ure 1, C and 1D). Modulation of tetherin due to infection
was not detected in tetherin
neg cells, since levels of cell
surface tetherin were below levels of detection at
baseline.
Tetherin localizes to cell-cell contacts
Tetherin might play a role in direct cell-to-cell spread of
HIV-1 in T-cells. We have confirmed that tetherin loca-
lizes on both sides of the contact zones between
infected and uninfected tetherin
pos cells by confocal
microscopy/immunofluorescence (Figure 2, bottom and
middle), as well as between uninfected cells (Figure 2,
middle and top). Further, tetherin co-localizes with actin
in the contact zones (Figure 2).
Equivalence of initial wt and Δvpu infection kinetics in
tetherin
pos and tetherin
neg cells
As the viral genes vpu and env are present in overlap-
p i n gf a s h i o ni nt h eH I V - 1g e n o m e ,w ei n v e s t i g a t e d
whether suppression of Vpu expression might also
impact the expression of Env. Western blots from viral
extracts confirmed that similar levels of Env were
expressed by both the wt and Δvpu viral clones, con-
firmed by similar Env band intensity, quantified relative
to CA p24, for wt (relative value: 1.97) and Δvpu virus
(relative value: 2.02) (Figure 3A). We then performed a
flow cytometry-based kinetic analysis of viral infection
with both the wt and Δvpu viral clones in tetherin
pos
and tetherin
neg cells during an initial 48 h post-infection.
Cells were infected with equal amounts of virus, as
determined by CA p24, and monitored for viral-derived
GFP expression immediately after infection and then
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Figure 1 Vpu down-modulates induced tetherin cell surface expression of tetherin
pos Sup-T1 cells. A. Western blot for Vpu (bottom) and
CA p24 (top) of wt- and Δvpu-infected cells. B. Tetherin expression levels upon induction over the course of 72 h. Tetherin cell surface
expression was induced by 100 ng/ml doxycycline and was detected by flow cytometry using a PerCP-labeled secondary antibody directed
against a primary anti-tetherin antibody. Data points are derived from three independent experiments. C. Histogram plot of representative
tetherin cell surface expression of non-induced (no dox./black) and induced (100 ng/ml) Sup-T1 cells (green), and induced cells infected with wt
(blue) and Δvpu (red) BR-NL43-IRES-eGFP viral clones, as well as control cells stained only with PerCP-labeled secondary antibody (Ab control/
grey). Cells were gated for infections via GFP expression as a marker for viral gene expression, 48 h post infection. D. Geometric means ±
standard error of the mean (SEM) of tetherin cell surface expression in uninfected cells and cells infected with wt and Δvpu BR-NL43-IRES-eGFP
viral clone. Data are derived from three independent experiments; error bars represent SEM.
AC BD
Figure 2 Tetherin co-localizes with actin at cell-cell contact zones. Confocal microscopy of co-cultured infected and uninfected tetherin
pos
cells, stained for actin, cell surface tetherin, and GFP, presented as single stains (A-C) and in an overlay image (D). Tetherin expression was
induced by 100 ng/ml doxycycline and detected using Alexa 647-labeled secondary antibody directed against a primary anti-tetherin antibody
(B). Actin was stained with Alexa 594 phalloidin (A); the virus derived GFP signal was amplified by GFP specific Alexa 488-labeled antibody (C).
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B and 3C). Statistical analysis of results obtained did not
reveal significant differences in regard to the presence/
absence of Vpu and tetherin (p > 0.5 for all time points).
This further confirms similar levels of Env expression in
wt and Δvpu viral clones; variations in Env expression
might otherwise impact on viral infection.
Establishment of a cell culture model to assess the effect
of tetherin on viral cell-to-cell transfer and transmission
We then set out to establish an assay that would assess
the impact of effector and target cell tetherin cell sur-
face expression on direct viral cell-to-cell spread, discri-
minating between viral transfer and viral transmission.
Tetherin
pos and tetherin
neg cells were infected with
equal amounts of wt or Δvpu virus (based on ng CA
p24) and cultured for 48 h, resulting in 10-12% infected
cells, as determined by measurement of GFP expression
by flow cytometry. Cells were washed, then co-cultured
with uninfected cells at a 2:1 (infected:uninfected) cell
ratio, which has been reported to increase viral spread
[26]. Uninfected tetherin
pos and tetherin
neg cells were
stained with CMAC, a dye allowing the tracking of
uninfected cells over multiple cell divisions, from 24 h
prior to the start of co-culture. Cells were then co-
cultured together to allow cell-cell contact or separated
by a membrane (3 μm pore size) in a transwell system
(Figure 4) that can exclude cells while permitting free
viral diffusion (data not shown) [26]. Samples were col-
lected at 6 h and 30 h after the initiation of co-culture
to assess viral transfer and transmission, respectively.
After 6 h, viral CA p24 was detected in target cells by
flow cytometry, indicating viral transfer, while expres-
sion of virus-derived GFP was not observed. After 30 h,
GFP was detected, indicating that viral transmission had
occurred.
Cells were stained for intracellular CA p24 and cell
surface tetherin. Flow cytometry analysis was performed
for CMAC (to identify previously uninfected target
cells), viral derived GFP, viral CA p24 and cell surface
tetherin. Cells were gated for live and single cells, fol-
lowed by gating for a CMAC positive target cell popula-
tion. The detection of viral CA p24 in this population
after 6 h allows identification and quantification of viral
transfer, while GFP expression in this population at
30 h is a measurement of virus transmission. While
other groups have detected viral transmission based on
intracellular CA p24 levels, we assessed viral transmis-
sion in terms the detection of virus-derived eGFP. Since
CA p24 expression in infected cells can per se not be
d i s t i n g u i s h e df r o mC Ap 2 4d e r i v e df r o mv i r a lt r a n s f e r ,
AB C
relative band intesity 
        gp120/p24
  wt     Δvpu
1.97     2.02
Figure 3 Neither tetherin nor Vpu affect viral kinetics of initial cell-free infection. A. Shown are representative Western blots of material
derived from wt and Δvpu viral particles stained for Env and CA p24 (top), as well as Env band intensity values, relative to CA p24, derived by
quantification of the representative Western blot using ImageJ software (bottom). Supernatants from 293T transfections were ultracentrifuged
and viral extracts analyzed by Western blot, normalized for CA p24. B&CTetherin
pos (B) and tetherin
neg (C) Sup-T1 cells were infected with wt
or Δvpu virus by spinoculation and cells were monitored for virus-derived GFP expression by flow cytometry. Data are derived from three
independent experiments; error bars represent SEM.
wt or Δvpu
48 h
6 h 24 h
6 h 24 h
Transfer
CAp24
Transmission
GFP
membrane 
Effector Cells Target Cells Infected Effector Cells
Transfer: Target Cell with CAp24 Transmission: Infected Target Cell 
Virus
Figure 4 Co-culture strategy and flow cytometry analysis.
Effector cells (grey) were infected with wt or Δvpu virus, cultured for
48 h, washed and then co-cultured with uninfected target cells,
which were stained with CMAC (blue) either together or separated
by a virus permeable membrane (3 μm pore size). Viral transfer was
assessed by flow cytometry analysis of viral CA p24 protein (yellow)
in target cells 6 h after the initiation of co-culture. Viral transmission
was assessed 24 h later by flow cytometry analysis for GFP
expression (green) in target cells.
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on controls, wherein synthesis of CA p24 is diminished
by antiviral drugs [26]. Our data show that our system,
which does not rely on drug controls, is at least as sen-
sitive in regard to detection of viral transmission (Sup-
plementary Figure 1). All experiments described below
examine viral transfer and transmission in the direct co-
culture, in which cell-cell (effector-target) contact can
occur. Examination of target cells in the transwell co-
cultures served as a control to show that cell-free viral
dissemination transfer was inefficient in the absence of
direct cell-cell contact [14]. While we present and dis-
cuss normalized data below, original readouts are pre-
sented in Supplementary Figure 2.
Tetherin expression on effector cells diminishes both viral
transfer and transmission and is antagonized by Vpu
Tetherin expression at the surface of effector cells
restricted transfer of Δvpu virus to tetherin
pos target cells
by 61% as assessed by intracellular CA p24 (Figure 5A)
(p = 0.0259). In contrast, transfer of wt virus was not sig-
nificantly affected by tetherin expression on the cell sur-
face of effector cells (Figure 5B) (p > 0.5). Therefore,
tetherin restricts viral transfer in direct cell-to-cell disse-
mination; Vpu antagonizest h i st e t h e r i n - m e d i a t e d
restriction.
We next decided to investigate the impact of tetherin
on viral transfer in greater detail by monitoring viral
transfer from tetherin
pos cells to either tetherin
pos or
tetherin
neg target cells in direct co-culture experiments.
The results show that transfer was increased by 140%
when Vpu was present (wt virus) compared to when
Vpu was absent (Δvpu) (p = 0.0235) (Figure 5C). Con-
versely, Vpu negatively affected viral transfer from
tetherin
neg to either tetherin
pos or tetherin
neg cells. Viral
transfer in the presence of Vpu (wt virus) reached only
70-80% of the levels of transfer that occurred in the
absence of Vpu (Δvpu) (p = 0.0235) (Figure 5D). No
GFP
pos cells were detected in the target cell population,
indicating that viral transfer but not transmission had
occurred. As flow cytometry detection was performed
on non-aggregated single cells, possible fusion events
between infected effector cells and target cells might not
have been assessed.
No CA p24 was detected after 6 h in any of the
potential target cell populations in transwell co-culture
experiments, where direct cell-cell contact had been
blocked, confirming the relative inefficiency of cell-free
viral transmission. An absence of CMAC
pos cells in the
effector cell population confirmed the integrity of the
transwell membrane.
As opposed to viral transfer, transmission and actual
infection of new cells must lead to expression of viral
genes. To examine the effect of tetherin on viral
transmission in direct cell-to-cell spread, cells were co-
cultured for 30 h and virus-derived GFP expression in
the target cell population was determined. When effec-
tor cells expressed tetherin, expression of GFP from wt
virus in target cells was 200-230% of levels attained with
Δvpu virus (p = 0.0235) (Figure 5E). In contrast, when
effector cells failed to express surface tetherin, transmis-
sion of wt virus was apparently reduced to 55-66% of
levels attained with Δvpu virus (p = 0.0235) (Figure 5F).
No GFP was detected in target cell populations in any
transwell culture after 30 h, confirming the relative inef-
ficiency of cell-free viral transmission.
Tetherin expression on target cells promotes viral
transfer and viral transmission
We next asked whether tetherin expression on target
cells impacts viral cell-to-cell transfer. We found that
tetherin expression on target cells significantly
increased transfer of both wt and Δvpu virus, irrespec-
tive of the presence or absence of tetherin on effector
cells. When the latter expressed tetherin, transfer of
both wt and Δvpu virus to tetherin
neg target cells was
20% lower than to tetherin
pos cells (p = 0.0235) (Figure
6A). Similarly, when effector cells lacked tetherin sur-
face expression, transfer of both wt and Δvpu virus to
tetherin
neg target cells was reduced by 20% and 27%,
respectively, compared to transfer to tetherin
pos target
cells (p = 0.0223) (Figure 6B).
Further to this, we observed 21% and 30% decreases
in transmission of wt and Δvpu virus from tetherin
pos
effector cells to tetherin
neg target cells, respectively,
compared to transmission of these viruses to tetherin
pos
cells (p = 0.02) (Figure 6C). Similar decreases were obtained
for transmission of wt (24%) and Δvpu (27%) virus from
tetherin
neg effector cells (p = 0.0235) (Figure 6D).
Tetherin does not impact the infectiousness of
transferred HIV-1
The above result document a differential effect of Vpu
on viral transfer and transmission, depending on
tetherin surface expression on effector cells, and a Vpu-
independent effect of tetherin surface expression on tar-
get cells. We next asked whether these factors might
impact on viral infectivity in cell-to-cell transmission by
calculating ratios of viral transmission and transfer. By
deriving transmission vs. transfer ratios between wt and
Δvpu virus, we assessed the effect of Vpu (Figure 7).
Significant differences were not observed (p > 0.05), sug-
gesting that cell surface tetherin expression did not
affect viral infectiousness in regard to direct cell-to-cell
dissemination. However, when effector cells lacked
tetherin, the ratio was increased by ~25%, irrespective of
the presence or absence of tetherin on target cells. This
suggests that there is a fitness cost associated with Vpu
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not express tetherin.
Discussion
Tetherin is an IFN-a-inducible antiviral factor that func-
tions in innate immunity by linking nascent virus to the
cellular surface and inhibiting virus release [3,5]. The
Vpu-mediated countermeasure is localized to lipid rafts
at the cell surface [3,5,6,35,38,39]. Lipid rafts are sites of
polarized cell-cell contact in immunological and virolo-
gical synapses [13,17,18,20,21,53].
Here, we have investigated how cell surface expression
of tetherin on effector and target cells can modulate
cell-to-cell transfer and transmission of HIV-1. To this
end we used a T-cell line, Sup-T1, inducible for human
tetherin expression [9]. In contrast to cell lines or pri-
mary cells, wherein tetherin expression can be achieved
as part of the cellular antiviral state via the multifaceted
AB
CD
F E
Figure 5 Tetherin cell surface expression on effector cells inhibits viral cell-to-cell transfer and transmission and is counteracted by Vpu.
Tetherin
pos or tetherin
neg Sup-T1 effector cells, infected with wt or Δvpu virus, were co-cultured with tetherin
pos or tetherin
neg Sup-T1 target cells.
Target cells were assessed for viral transfer and viral transmission by flow cytometry analysis for CA p24 and GFP expression, respectively. Data are
derived from three independent experiments; error bars represent SEM. A&B . Viral transfer (CA p24) of Δvpu (A) and wt (B) virus from tetherin
pos
and tetherin
neg effector cells. Data are normalized to the number of infected tetherin
neg effector cells. C&D . Viral transfer (CA p24) of wt and Δvpu
virus from tetherin
pos (C) and tetherin
neg (D) effector cells. Data are normalized for Δvpu infections in each case. E&F . Viral transmission (GFP) of wt
and Δvpu virus from tetherin
pos (E) and tetherin
neg (F) effector cells. Data are normalized for Δvpu infections in each case.
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Page 7 of 13IFN-response, use of the doxycycline-inducible cell-line
allowed us to exclusively investigate the contribution of
tetherin on cell-to-cell spread.
In our system, tetherin surface levels in these HIV-1
infected tetherin
pos cells were down-regulated in a Vpu-
dependent manner (Figure 1), confirming the role of Vpu
in counteracting tetherin, for which the underlying
mechanisms are not yet fully understood [5,7,9,36,54].
However, infection of these cells with Δvpu virus caused
tetherin cell surface levels to be up-regulated when com-
pared to non-infected cells. This observation is not due
non-specific staining, as ruled out by internal controls for
the primary and secondary antibody (Figure 3C, compar-
ing uninduced (black) and control staining (grey)). We
speculate that this effect is most likely due to a tethering
of viral particles to the cell surface and subsequent
greater accessibility of tetherin to antibody binding,
though this hypothesis requires investigation. Another
potential explanation could be the cell surface increase in
infected cells due to swelling in infected cells.
In the viral genome, the Vpu and Env proteins are
encoded in overlapping fashion. As we introduced
B A
C D
Figure 6 Tetherin cell surface expression on target cells promotes viral cell-to-cell transfer and transmission. Tetherin
pos or tetherin
neg
Sup-T1 effector cells, infected with wt or Δvpu virus, were co-cultured with tetherin
pos or tetherin
neg Sup-T1 target cells. Target cells were
assessed for viral transfer and viral transmission by flow cytometry analysis for CA p24 and GFP expression, respectively. Data are normalized for
tetherin
pos target cells in each case. Data are derived from three independent experiments; error bars represent SEM. (A&B ) . Viral transfer (CA
p24) of wt and Δvpu virus from tetherin
pos (A) and tetherin
neg (B) effector cells. (C&D ) . Viral transmission (GFP) of wt and Δvpu virus from
tetherin
pos (C) and tetherin
neg (D) effector cells.
Figure 7 Tetherin does not affect infectiousness of transferred
virus. Tetherin
pos or tetherin
neg effector cells, infected with wt or
Δvpu virus, were co-cultured with tetherin
pos or tetherin
neg target
cells. Ratios of transmission vs transfer were calculated; ratios of
Δvpu and wt infections were compared to determine the impact of
tetherin and Vpu on viral infectivity. A ratio of one indicates similar
viability of the Δvpu and the wt virus. Ratios <1 represent an
advantage for Vpu (wt virus), while a ratio >1 indicates a fitness cost
of Vpu (Δvpu virus) in viral cell-to-cell spread. Data are derived from
three independent experiments; error bars represent SEM.
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Page 8 of 13premature stop codons into the coding region of vpu by
site-directed mutagenesis to generate a Δvpu viral clone,
we assessed and confirmed the similarity of viral Env
levels in wt and Δvpu viral particles (Figure 3A). There-
fore, differences in cell-to-cell spread in regard to Vpu-
mediated tetherin downmodulation are independent of
potential variation of Env expression. Further, we also
confirmed similarity of cell-free viral infection kinetics
in tetherin
pos and tetherin
neg cells (Figure 3, B and 3C)
Confocal microscopy revealed cell surface tetherin
focused on cell-cell contact zones between infected and
uninfected cells, as well as between uninfected cells,
where it co-localized with actin (Figure 2). Therefore,
tetherin is adequately positioned to modulate cell-to-cell
spread of HIV-1. We established a flow cytometry assay
to assess the impact of tetherin cell surface expression
on viral cell-to-cell spread (Figure 4). In contrast to
other similar assays [26], ours has the advantage of dis-
tinguishing between viral transfer and infection in the
same cell population. This was accomplished by detec-
tion of intracellular viral CA p24 protein as a marker of
viral transfer vs the expression of virus-derived GFP as a
marker of infection. Employing an eGFP-expressing
reporter virus is crucial to this assay in order to distin-
guish transfer from transmission, since transferred CA
p24 cannot be easily distinguished from newly synthe-
sized CA p24 by staining and flow cytometry. Rather,
this distinction relies on control experiments that
employed inhibitors of reverse transcriptase to abrogate
new synthesis of CA p24 in infected cells [26]; however,
it is not known to what extent cell-to-cell spread may
be impervious to inhibitors of reverse transcription, neu-
tralizing antibodies, and inhibitors of viral entry
[14,31,33,55]. In our system, the presence of Efavirenz
(500 nM) only partially reduced infection of target cells
(Supplementary Figure 1). Change in CA p24 mean
fluorescence intensity might not directly reflect produc-
tive infection (Supplementary Figure 1). In our studies
we used a reporter virus, wherein eGFP is encoded by
means IRES adjacent to nef, and is therefore expressed
early in viral infection [56-58]. Therefore, in our system,
the absence of GFP in target cells at the transfer time
point (6 h) is a valid control; CA p24 detected in target
cells at this time is exclusively derived from transfer
events. This set up also enabled us to calculate an infec-
tivity ratio, derived from the percentage of cells expres-
sing viral genes after 30 h versus the percentage of cells
showing evidence of viral transfer after 6 h. Further-
more, a comparison of such ratios using either wt or
Δvpu viruses allowed us to investigate the interrelation-
ship between Vpu and tetherin in regard to viral cell-to-
cell spread.
Using this system, we have shown that induction of
tetherin at the effector cell surface significantly
diminishes cell-to-cell transfer of Δvpu virus (Figure 5A).
Viral Vpu antagonizes this restriction; transfer of wt virus
was not significantly affected by tetherin (Figure 5B).
Therefore, tetherin-mediated accumulation of HIV-1 par-
ticles at the cell surface does not increase viral cell-to-cell
spread of HIV-1, as occurs with HTLV-1 [42].
We observed 2-fold increases in both viral transfer
and transmission of wt virus compared to Δvpu virus
from tetherin
pos effector cells (Figure 5, C and 5E).
Recent studies on the effect of Vpu on viral release have
shown increases of 2-70 fold as assessed by extracellular
CA p24 [3,5,8,9,34]. Direct cell-to-cell spread of HIV
may be 100-18,000 times more efficient than cell-free
spread [10,14,59].
Our data show that direct viral transfer and transmis-
sion were affected by tetherin to similar extents, indict-
ing that the reduction in viral transmission is directly
related to the reduction in viral transfer. However, we
found that Δvpu virus spread more efficiently from
tetherin
neg cells than wt virus (Figure 5), a result consis-
tent with reports by others of increased transfer of Δvpu
virus [26,28].
When assessing the infectivity of the transferred virus
in cell-to-cell dissemination, we did not observe an
overall statistically significant effect of tetherin that was
expressed on the surface of effector cells or of its Vpu-
mediated down-modulation. However, we report the
apparently increased infectiousness of Δvpu virus when
effector cells lacked tetherin expression (Figure 7). This
observation, together with the more efficient dissemina-
tion of Δvpu virus than wt virus from tetherin
neg cells
(Figure 5), suggests the faster replication of Δvpu virus
in this setting (cell-to-cell spread) but not during the
initial (cell-free) phase of infection, which proved not to
be affected by Vpu, irrespective of the presence/absence
of tetherin at the cell surface (Figure 3, B and 3C). This
further suggests that Vpu imposes a fitness cost in
terms of cell-to-cell viral dissemination when tetherin is
absent. This effect seems to be related only to direct
cell-to-cell viral spread, but not to cell-free spread, as
initial cell-free infections were not affected (Figure 3, B
and 3C). This is further supported by the selection of a
Δvpu mutant in a co-culture study that used the Jurkat
T-cell line [28].
Surprisingly, we found that tetherin expression on tar-
get cells led to higher levels of viral transfer and trans-
mission. This effect was independent of tetherin cell
surface expression in effector cells (Figure 6). Even
though the observed effect was modest, it was found to
be statistically significant. As this effect would occur in
the setting of highly effective direct cell-to-cell spread,
the ultimate impact of even a modest increase in trans-
m i s s i o nm i g h tb el a r g ea n di n d i c a t e sal i k e l yr o l ef o r
tetherin on target cells in the virological synapse. In
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[35,38]; its expression via IFN-a is stimulated as a
response to viral infections [5,60]. Tetherin can also
modulate the actin cytoskeleton of polarized and non-
polarized cells and is thought to link actin architectures
and cellular membranes [35,37,38]. It is therefore possi-
ble that cell surface tetherin expression modulates the
virological synapse and subsequently influences cell-to-
cell transfer and transmission, but not cell free infection,
which is not dependent on synapse formation. Such
modulation could occur through stabilization of synapse
structure on both effector and target cell and/or actin-
dependent recruitment of viral receptors that are neces-
sary for entry on the target cell [13,61]. This is in agree-
ment with the observed co-localization of tetherin and
actin in the contact zone of effector and target cells
(Figure 2). Recently, it was proposed that HIV-1 can
spread between T-cells via actin-containing membrane
extensions in a receptor-dependent manner [30,62].
HIV-1 may hijack the IFN-a-mediated innate immune
response in order to increase the efficiency of viral
spread. These ideas are speculative, based on an under-
standing of the current literature.
During the preparation of this manuscript, another
study reported that tetherin expression restricts cell-to-
cell transmission of HIV-1 and that such restriction is
antagonized by Vpu [49]. In addition, a different study
reported that cell-to-cell HIV spread is not affected by
tetherin [48]. Our experiments enabled us to assess viral
transfer and transmission in the same cell population,
by using a stably transduced cell line that is inducible
for tetherin expression for both effector and target cells.
Thus, we were able to investigate tetherin-mediated
effects independent of differences in cell lines and inde-
pendent of the complex cellular response to IFN.
Although an IFN approach is probably more physiologi-
cally relevant, our system has limited the variables to
tetherin and Vpu only and shows similar tetherin-
mediated effects on transfer and transmission. Although
generally in agreement in regard to tetherin-mediated
restriction of cell-to-cell viral spread, one study reported
a discordance between transfer and transmission, sug-
gesting an impact of tetherin on viral infectivity [49].
While we report results showing that tetherin might
reduce the infectivity of the Δvpu virus to levels equiva-
lent to those of wt virus (Figure 7), a different study
reported reduced infectivity of a Δvpu virus compared
to wt and attributed this to tetherin [49]. Others showed
an impact of tetherin on the formation of virological
synapses [48,49], but did not specifically test for an
effect of tetherin in target cells in regards to cell-to-cell
spread, as has been performed here. Specifically, one
study reported an increase in synapse formation in the
presence of tetherin [48], which is supportive of our
finding that tetherin promotes cell-to-cell spread when
expressed on target cells. This result also supports our
hypothesis that tetherin plays a role in synapses and
that Vpu might represent a modulator of synapse invol-
vement via tetherin. Differences in regard to restriction
of cell-to-cell spread of HIV-1 by tetherin [48,49] might
be due to differential methodology and analysis (flow
cytometry detection of CA p24 and virus-derived eGFP
expression compared to flow cytometry detection of
changes in CA p24 levels, scanning electron microscopy,
and qPCR of RT products). Importantly, there were also
differences between these studies in the source of
tetherin used as well as tetherin expression levels, and
tetherin modulation (stably transduced cell line, induci-
ble for tetherin expression, compared to primary cells,
as well as various cell lines with different expression
levels, transfections, and IFN stimulation paired with
anti-tetherin shRNA). These factors might fundamen-
tally impact on the outcome of the studies, and might
also explain the tetherin-mediated effect on infectivity of
released virus as recently reported by others [63].
Recent findings that HIV-2 Env and SIV Nef exhibit
Vpu-like function in down-modulating tetherin from the
cell surface (without down-modulating CD4, in the case
of HIV-2) underline the importance of countering
tetherin-mediated restriction [64,65]. Some have argued
that tetherin activity may be important in restricting
cross-species transmission of HIV and its diversification
[66]. Although it is accepted that tetherin restricts the
cell-free dissemination of HIV-1, it will be of importance
to further address whether tetherin can affect other
aspects of cell-to-cell spread, which can occur with high
efficiency. Our data provide support for a role of tetherin
in restricting the cell-to-cell spread of HIV-1 [49].
Conclusions
We have shown that tetherin, in addition to limiting
cell-free viral spread, also restricts direct cell-to-cell
spread of HIV-1. Virus transfer and transmission were
both affected by tetherin and restriction, in each case,
w o u l db eo v e r c o m eb yt h ev i r a lp r o t e i nV p u ,w h i c h
down-modulates tetherin from the cell surface. The
observation that Vpu is necessary for cell-to-cell spread
from tetherin-expressing cells, but is disadvantageous in
tetherin-free settings, suggests that Vpu presents a fit-
ness cost to the virus in regard to cell-to-cell spread,
that is outweighed by its ability to antagonize tetherin.
The differential role of tetherin in effector and target
cells suggests a role for tetherin in cell-cell contacts and
virological synapses. Targeting Vpu and promoting
tetherin-mediated restriction should be advanced as an
antiviral strategy.
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Additional file 1: Supplementary Figure 1. Evaluation of sensitivity
of detection of transmission. Virus transmission in untreated target
cells and in cells treated with Efavirenz (EFV; 500 nM) was based on the
detection of intracellular CA p24 or virus derived eGFP at 30 h of co-
culture with infected effector cells. A&B . Percentages of cells gated
positive for CA p24 (A) or eGFP (B) in the absence or presence of EFV.
Differences between the EFV-treated and untreated cells were statistically
significant (A: p = 0.0005; B: p = 0.0001; Student’s t-test). Data show three
independent experiments; error bars represent SEM. C. Detection of eGFP
is more sensitive than detection of CA p24. Shown is a summary of
means ± SEM, differences of means ± SEM, and differences normalized
to the no-drug control (% change) from cells gated positive for CA p24
and eGFP. D-G. Changes in mean fluorescence intensity might not reflect
infection. Shown are target cells gated positive for CA p24 (red) and
eGFP (blue), in regard CAp24 fluorescence (% cells of target cell
population) (D&F ) and mean fluorescence intensity (geometric means)
(E&G ). Cells were cultured in the absence (D&E ) or the presence of
EFV (500 nM; F&G ). While eGFP positive target cells clearly show high
CA p24 levels in the absence of drug (D&E ), eGFP positive cells are also
present in the drug-treated target cell population (F); geometric mean
differences between eGFP positive and CA p24 positive, drug-treated,
target cells are less pronounced (G) and might lead to an underestimate
of transmission events. Therefore, the detection of transmission events
might be less sensitive than observed through direct detection of virus-
derived eGFP.
Additional file 2: Supplementary Figure 2. Original data from three
independent experiments. Shown are tabular data of transfer (top),
transmission (middle) and infectivity ratios (bottom) for three
experiments (Experiments 1-3); numbers represent % of target cell
population. Virus transfer was detected by intracellular staining for CA
p24 in target cells at 6 h of co-culture; transmission was assessed via
detection of virus-derived eGFP expression in target cells at 30 h of co-
culture.
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